Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. Article

authors

  • Wallace, DK
  • Kraker, RT
  • Freedman, SF
  • Crouch, Eric
  • Hutchinson, AK
  • Bhatt, AR
  • Rogers, DL
  • Yang, MB
  • Haider, KM
  • VanderVeen, DK
  • Siatkowski, RM
  • Dean, TW
  • Beck, RW
  • Repka, MX
  • Smith, LE
  • Good, WV
  • Hartnett, ME
  • Kong, L
  • Holmes, JM
  • Pediatric Eye Disease Investigator Group, (PEDIG).

publication date

  • 2017

published in

PubMed Central ID

  • pmc5521814

number of pages

  • 2

start page

  • 654

end page

  • 656

volume

  • 135

issue

  • 6